JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 25, 2008
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/4/1839    most recent
M704576200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christoffersen, C.
Right arrow Articles by Nielsen, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christoffersen, C.
Right arrow Articles by Nielsen, L. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print November 15, 2007
J. Biol. Chem, 10.1074/jbc.M704576200
Submitted on June 4, 2007
Revised on October 22, 2007
Accepted on November 15, 2007

Effect of apolipoprotein M on HDL metabolism and atherosclerosis in LDL receptor knockout mice

Christina Christoffersen, Matti Jauhiainen, Markus Moser, Bo Porse, Christian Ehnholm, Michael Boesl, Björn Dahlbäck, and Lars Bo Nielsen

Clinical Biochemistry, Rigshospitalet, Copenhagen 2100

Corresponding Author: christina.christoffersen{at}rh.regionh.dk

To investigate the role of apoM in HDL metabolism and atherogenesis, we generated human apoM transgenic (apoM-Tg) and apoM-deficient (apoM-/-) mice. Plasma apoM was predominantly associated with 10-12 nm-sized a-migrating HDL particles. Human apoM overexpression (11-fold) increased plasma cholesterol concentration by 13-22%, whereas apoM deficiency decreased it by 17-21%. The size and charge of apoA-I-containing HDL in plasma were not changed in apoM-Tg or apoM-/- mice. However, in plasma incubated at 37ºC, lecithin:cholesterol acyltransferase (LCAT)-dependent conversion of a- to prea-migrating HDL was delayed in apoM-Tg mice. Moreover, LCAT-independent generation of preß-migrating apoA-I-containing particles in plasma was increased in apoM-Tg mice (4.2±1.1%, P=0.06) and decreased in apoM-/- mice (0.5±0.3%, P=0.03) vs. controls (1.8±0.05%). In the setting of LDL-receptor deficiency, apoM-Tg mice with ~2-fold increased plasma apoM concentrations developed smaller atherosclerotic lesions than controls. The effect of apoM on atherosclerosis may be facilitated by enzymatic modulation of plasma HDL particles, increased cholesterol efflux from foam cells, and an antioxidative effect of apoM-containing HDL.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
J. Ahnstrom, O. Axler, M. Jauhiainen, V. Salomaa, A. S. Havulinna, C. Ehnholm, R. Frikke-Schmidt, A. Tybjaerg-Hansen, and B. Dahlback
Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies
J. Lipid Res., September 1, 2008; 49(9): 1912 - 1917.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Wolfrum, J. J. Howell, E. Ndungo, and M. Stoffel
Foxa2 Activity Increases Plasma High Density Lipoprotein Levels by Regulating Apolipoprotein M
J. Biol. Chem., June 13, 2008; 283(24): 16940 - 16949.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.